Toru Nakamura Selected Research

Lymphatic Metastasis

12/2023	Reconsidering resectable oncological conditions in pancreatic tail cancer: A multicenter retrospective study on prognostic factors in pancreatic tail cancer after resection (HOPS Pt-01).
1/2021	Transhepatic Direct Approach to the "Limit of the Division of the Hepatic Ducts" Leads to a High R0 Resection Rate in Perihilar Cholangiocarcinoma.
9/2020	Laparoscopic-assisted distal gastrectomy and central pancreatectomy for gastric and perigastric lymph node metastases and pancreatic invasion from melanoma: a case report.
2/2018	Impact of serum carbohydrate antigen 19-9 level on prognosis and prediction of lymph node metastasis in patients with intrahepatic cholangiocarcinoma.
7/2008	Modification of the primary tumor microenvironment by transforming growth factor alpha-epidermal growth factor receptor signaling promotes metastasis in an orthotopic colon cancer model.
12/2006	Targeting the expression of platelet-derived growth factor receptor by reactive stroma inhibits growth and metastasis of human colon carcinoma.
12/2006	Therapy of multidrug resistant human prostate tumors in the prostate of nude mice by simultaneous targeting of the epidermal growth factor receptor and vascular endothelial growth factor receptor on tumor-associated endothelial cells.
6/2006	Targeting platelet-derived growth factor receptor on endothelial cells of multidrug-resistant prostate cancer.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Toru Nakamura Research Topics

Disease

83	Neoplasms (Cancer) 02/2024 - 03/2004
26	Pancreatic Neoplasms (Pancreatic Cancer) 09/2022 - 03/2004
20	Adenocarcinoma 02/2024 - 03/2004
16	Hepatocellular Carcinoma (Hepatoma) 02/2024 - 05/2004
15	Neoplasm Metastasis (Metastasis) 10/2020 - 04/2006
12	Liver Cirrhosis (Hepatic Cirrhosis) 03/2024 - 03/2006
9	Klatskin Tumor 01/2024 - 08/2014
9	Colonic Neoplasms (Colon Cancer) 03/2016 - 05/2005
8	Fibrosis (Cirrhosis) 12/2024 - 03/2006
8	Lymphatic Metastasis 12/2023 - 06/2006
8	Carcinoma (Carcinomatosis) 06/2022 - 12/2006
7	Cholangiocarcinoma 12/2023 - 07/2014
7	Wounds and Injuries (Trauma) 02/2022 - 04/2013
7	Stomach Neoplasms (Stomach Cancer) 05/2021 - 11/2013
6	Inflammation (Inflammations) 02/2018 - 07/2009
5	Infections 09/2022 - 01/2002
5	Hemorrhage 04/2020 - 11/2005
5	Schizophrenia (Dementia Praecox) 01/2017 - 11/2014
5	Body Weight (Weight, Body) 11/2016 - 04/2006
4	Hypoxia (Hypoxemia) 01/2023 - 06/2012
4	Pancreatic Fistula (Pancreatic Fistulas) 01/2023 - 12/2018
4	Pain (Aches) 05/2022 - 03/2016
4	Margins of Excision 01/2021 - 04/2015
4	Carcinogenesis 01/2016 - 03/2004
4	Hyperuricemia 01/2013 - 04/2008
3	Liver Neoplasms (Liver Cancer) 08/2023 - 03/2012
3	Lung Neoplasms (Lung Cancer) 11/2022 - 01/2018
3	Liver Failure 06/2022 - 01/2016
3	Breast Neoplasms (Breast Cancer) 05/2022 - 01/2005
3	Prostatic Neoplasms (Prostate Cancer) 01/2022 - 06/2006
3	Melanoma (Melanoma, Malignant) 09/2020 - 12/2006
3	Ascites 12/2019 - 05/2014
3	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2019 - 03/2009
3	Surgical Wound Infection 09/2018 - 08/2010
3	Primitive Neuroectodermal Tumors (PNET) 12/2017 - 12/2014
3	Non-alcoholic Fatty Liver Disease 11/2013 - 07/2009
2	Fatty Liver 03/2024 - 01/2017

Drug/Important Bio-Agent (IBA)

11	Biomarkers (Surrogate Marker)IBA 02/2023 - 11/2014
9	AntigensIBA 02/2023 - 01/2005
9	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2016 - 04/2006
8	Complementary DNA (cDNA)IBA 02/2023 - 03/2004
8	Proteins (Proteins, Gene)FDA Link 01/2020 - 04/2006
8	ErbB Receptors (EGF Receptor)IBA 07/2012 - 12/2006
6	erucylphosphocholineIBA 01/2016 - 03/2006
5	Uric Acid (Urate)IBA 12/2014 - 04/2008
5	Platelet-Derived Growth Factor Receptors (Platelet-Derived Growth Factor Receptor)IBA 02/2008 - 06/2006
4	Carcinoembryonic AntigenIBA 11/2023 - 01/2005
4	Tumor Biomarkers (Tumor Markers)IBA 02/2023 - 03/2004
4	Fluorouracil (Carac)FDA LinkGeneric 11/2022 - 03/2011
4	Vascular Endothelial Growth Factor Receptors (VEGF Receptors)IBA 03/2011 - 12/2006
4	Irinotecan (Camptosar)FDA LinkGeneric 05/2008 - 12/2006
3	Granulocyte Colony-Stimulating Factor (G-CSF)IBA 12/2024 - 01/2002
3	Serum AlbuminIBA 11/2023 - 05/2014
3	Immune Checkpoint InhibitorsIBA 10/2023 - 09/2020
3	LigandsIBA 08/2023 - 02/2008
3	Cadherins (E-Cadherin)IBA 03/2023 - 04/2005
3	Tyrosine Kinase InhibitorsIBA 01/2023 - 05/2008
3	ProdrugsIBA 11/2022 - 03/2011
3	Flucytosine (Ancobon)FDA Link 11/2022 - 03/2012
3	Cytosine DeaminaseIBA 11/2022 - 03/2012
3	Triclosan (pHisoHex)FDA Link 02/2022 - 04/2013
3	CarbohydratesIBA 01/2022 - 01/2005
3	CytokinesIBA 07/2020 - 04/2010
3	Alanine Transaminase (SGPT)IBA 02/2018 - 04/2006
3	Peptides (Polypeptides)IBA 12/2017 - 05/2005
3	Indicators and Reagents (Reagents)IBA 04/2017 - 03/2015
3	pentosidineIBA 01/2017 - 11/2014
3	Matrix Metalloproteinases (MMPs)IBA 10/2014 - 07/2007
3	Messenger RNA (mRNA)IBA 11/2013 - 05/2004
3	Epidermal Growth Factor (EGF)IBA 07/2012 - 12/2006
3	Vascular Endothelial Growth Factor Receptor-2 (Vascular Endothelial Growth Factor Receptor 2)IBA 07/2012 - 01/2008
3	Transforming Growth Factor alpha (TGF-alpha)IBA 07/2008 - 12/2007
3	AEE 788 (AEE788)IBA 01/2008 - 12/2006
3	Imatinib Mesylate (Gleevec)FDA Link 01/2008 - 06/2006
2	Hydroxyproline (4 Hydroxyproline)IBA 03/2024 - 07/2020
2	Amino Acids FDA Link 03/2024 - 02/2023
2	MicroRNAs (MicroRNA)IBA 02/2024 - 11/2013
2	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 02/2024 - 01/2023
2	Histones (Histone)IBA 12/2023 - 11/2013
2	lenvatinibIBA 10/2023 - 04/2020
2	RNA (Ribonucleic Acid)IBA 10/2023 - 10/2020
2	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 08/2023 - 01/2008
2	AntibodiesIBA 08/2023 - 02/2023

Therapy/Procedure

33	Therapeutics 12/2024 - 01/2002
13	Drug Therapy (Chemotherapy) 01/2024 - 01/2002
12	Pancreatectomy 01/2023 - 03/2014
10	Gastrectomy 05/2021 - 12/2015
10	Pancreaticoduodenectomy 01/2021 - 06/2014
9	Lymph Node Excision (Lymph Node Dissection) 09/2022 - 09/2012
9	Hepatectomy 09/2022 - 02/2015
7	Transplantation 10/2014 - 03/2006
6	Neoadjuvant Therapy 01/2022 - 05/2016
5	Sutures (Suture) 02/2022 - 04/2013
5	Esophagectomy 09/2021 - 06/2017
4	Lasers (Laser) 08/2007 - 03/2004
3	Cell Transplantation 03/2024 - 04/2012
3	Immunotherapy 10/2023 - 05/2005
3	Chemoradiotherapy 06/2019 - 04/2015
2	Polypharmacy 02/2024 - 01/2017
2	Palliative Care (Palliative Therapy) 02/2024 - 04/2020